Ezetimibe/atorvastatin

From WikiMD's WELLNESSPEDIA

Ezetimibe/atorvastatin is a medication used in the treatment of high cholesterol. It is a combination of two drugs, ezetimibe and atorvastatin, which work together to lower the levels of "bad" cholesterol (low-density lipoprotein, or LDL) and triglycerides in the blood, while increasing levels of "good" cholesterol (high-density lipoprotein, or HDL).

Etymology[edit]

The name "ezetimibe" is derived from the chemical name "(3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one". The name "atorvastatin" comes from the chemical name "[[R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid]]".

Pharmacology[edit]

Ezetimibe works by reducing the amount of cholesterol absorbed by the body, while atorvastatin inhibits an enzyme in the liver that produces cholesterol. The combination of these two drugs is more effective at lowering cholesterol levels than either drug alone.

Uses[edit]

Ezetimibe/atorvastatin is used to treat high cholesterol and to reduce the risk of heart disease, stroke, and other cardiovascular diseases. It is typically prescribed to patients who have not been able to lower their cholesterol levels through diet and exercise alone.

Side Effects[edit]

Common side effects of ezetimibe/atorvastatin include headache, muscle pain, and diarrhea. Serious side effects can include liver problems and a rare but serious muscle condition called rhabdomyolysis.

Related Terms[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.